The “2026 Premium Cataract Surgery Market Report” examines a global PCS market that continues to expand rapidly as premium IOL adoption grows, refractive lens exchange (RLE) gains acceptance, and new technologies create additional opportunities for growth. The report explores several developments that could shape the market’s next phase, including Alcon and RxSight’s work to develop a post-op adjustable trifocal IOL and AI’s influence on lens design, IOL selection, patient education, and surgical workflow.
The 2026 edition significantly expands its country-level analysis to help competitors better identify and compare opportunities across the world’s leading PCS markets. Each of the 13 top countries now feature a market attractiveness scorecard evaluating its potential for PCS product adoption, along with wealth metrics that provide greater context around the size and purchasing power of its elderly population, and lists of approved presbyopia-correcting IOLs alongside competitor share analysis.
The report also examines major regional shifts, such as how PCS product sales in Japan and South Korea continue to grow despite recent procedure declines following changes to balanced billing reimbursement.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.